Myris Therapeutics Employee Directory
Biotechnology ResearchPennsylvania, United States11-50 Employees
Myris Therapeutics, based in Pittsburgh, Pennsylvania, operates in the biotechnology research sector. It develops antibody-drug conjugates with very high drug-to-antibody ratios by combining traditional ADC design with next-generation polymer chemistry. The company maintains a compact, specialized team to advance this platform. Positioned in the ADC development space, its work targets the biotechnology and pharmaceutical research community seeking advanced conjugate technologies. In August 2022, the company announced the appointment of Mark Murcko, Ph.D., to its board.